These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 14145737)
1. [BLOOD COAGULATION PHENOMENA IN THE COURSE OF TREATMENT WITH COMBINED VINYLESTRENOLONE AND ETHINYLESTRADIOL]. MALAGOLI F; SIDERI L Gazz Med Ital; 1964 Apr; 123():116-8. PubMed ID: 14145737 [No Abstract] [Full Text] [Related]
2. PROGESTIN-ESTROGEN (SC 11,800) THERAPY AND THE HEMOSTATIC MECHANISM--A CONTROLLED STUDY. MILLER SP; LEE SL; RITZ N Metabolism; 1965 Mar; 14():SUPPL:398-410. PubMed ID: 14261424 [No Abstract] [Full Text] [Related]
3. [ON TREATMENT OF ESSENTIAL DYSMENORRHEA WITH VINYLESTRENOLONE-ETHINYLESTRADIOL COMBINATION]. ROGNONI V; ROSSI R Minerva Ginecol; 1964 Jan; 16():24-7. PubMed ID: 14124188 [No Abstract] [Full Text] [Related]
4. CIRCULATION, BLOOD COAGULATION, AND CLINICAL OBSERVATIONS DURING HORMONAL SUPPRESSION OF OVULATION. BREHM H Int J Fertil; 1964; 9():45-56. PubMed ID: 14106268 [No Abstract] [Full Text] [Related]
5. [HORMONAL INHIBITION OF OVULATION. METHODS, INDICATIONS, SIDE-EFFECTS, RESULTS]. KAISER R Dtsch Med Wochenschr; 1963 Nov; 88():2325-30. PubMed ID: 14111921 [No Abstract] [Full Text] [Related]
6. ORAL CONTRACEPTIVE HORMONES AND BLOOD COAGULABILITY. THOMSON JM; POLLER L Br Med J; 1965 Jul; 2(5456):270-3. PubMed ID: 14310204 [No Abstract] [Full Text] [Related]
7. [HORMONE EXCRETIONS AND BLOOD COAGULATION FACTORS DURING ORAL GESTAGEN-ESTROGEN THERAPY (EVALUATION OF THE RISK OF THROMBOPHLEBITIS)]. HALLER J; KOENIG A; POLIWODA H Geburtshilfe Frauenheilkd; 1965 Mar; 25():215-31. PubMed ID: 14289766 [No Abstract] [Full Text] [Related]
8. WHAT ARE THE DANGERS OF ORAL CONTRACEPTION? SWYER GI Proc R Soc Med; 1964 Mar; 57(3):210-2. PubMed ID: 14130875 [No Abstract] [Full Text] [Related]
9. [EARLY DIAGNOSIS OF PREGNANCY WITH THE VINYLESTRENOLONE-ETHINYLESTRADIOL]. D INCERTIBONINI L; PAGANI C Ann Ostet Ginecol; 1964 Feb; 86():103-28. PubMed ID: 14156044 [No Abstract] [Full Text] [Related]
10. BLOOD COAGULABILITY AND ORAL CONTRACEPTION. PILGERAM LO Br Med J; 1964 Apr; 1(5387):883-4. PubMed ID: 14102773 [No Abstract] [Full Text] [Related]
11. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
12. EVALUATION OF A NEW PROGESTIN. CROWSON LB; WINER BA; NOYES RW Obstet Gynecol; 1965 Sep; 26():349-55. PubMed ID: 14341200 [No Abstract] [Full Text] [Related]
13. INHIBITORY EFFECT OF LYNESTRENOL AND LYNDIOL ON HUMAN OVARIAN FUNCTION. BORGLIN NE Int J Fertil; 1964; 9():17-23. PubMed ID: 14106254 [No Abstract] [Full Text] [Related]
14. MEDICAL ASPECTS OF ORAL CONTRACEPTIVES. LEATHER HM Lancet; 1965 Jan; 1(7379):270-1. PubMed ID: 14238082 [No Abstract] [Full Text] [Related]
15. COMPLICATIONS OF ORAL CONTRACEPTION. HARTVEIT F Br Med J; 1965 Jan; 1(5426):60-1. PubMed ID: 14213119 [No Abstract] [Full Text] [Related]
16. [ETHYNODIOL DIACETATE (SC 11800) IN THE TREATMENT OF LUTEAL INSUFFICIENCY]. BERNARD I Ann Endocrinol (Paris); 1964; 25():179-82. PubMed ID: 14163475 [No Abstract] [Full Text] [Related]
17. THE INHIBITION OF OVULATION WITH ORAL PROGESTATIVE SUBSTANCES. KAISER R Int J Fertil; 1964; 9():87-93. PubMed ID: 14106272 [No Abstract] [Full Text] [Related]
18. [STUDY OF BLOOD COAGULATION FACTORS DURING GESTAGEN TREATMENT]. SAS M; GABOR M; KOVACS L; NEMETH I; SZONTAGH F Orv Hetil; 1964 Jul; 105():1353-5. PubMed ID: 14181915 [No Abstract] [Full Text] [Related]
19. THE USE OF PROGESTINS IN OBSTETRICS AND GYNECOLOGY. FLOWERS CE N C Med J; 1964 Apr; 25():139-45. PubMed ID: 14143212 [No Abstract] [Full Text] [Related]
20. OVARIAN INHIBITION WITH ETHYNODIOL-DIACETATE: INFLUENCE ON STEROIDOGENESIS. VANEK R Int J Fertil; 1964; 9():129-35. PubMed ID: 14106245 [No Abstract] [Full Text] [Related] [Next] [New Search]